Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Non Operating Investment Income (2022 - 2025)

Historic Non Operating Investment Income for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $29000.0.

  • Orchestra BioMed Holdings' Non Operating Investment Income fell 7603.31% to $29000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$183000.0, marking a year-over-year increase of 2406.64%. This contributed to the annual value of -$68000.0 for FY2024, which is 27777.78% down from last year.
  • Latest data reveals that Orchestra BioMed Holdings reported Non Operating Investment Income of $29000.0 as of Q3 2025, which was down 7603.31% from -$21000.0 recorded in Q2 2025.
  • Over the past 5 years, Orchestra BioMed Holdings' Non Operating Investment Income peaked at $1.7 million during Q2 2022, and registered a low of -$314000.0 during Q3 2022.
  • For the 4-year period, Orchestra BioMed Holdings' Non Operating Investment Income averaged around $54133.3, with its median value being -$27000.0 (2023).
  • Data for Orchestra BioMed Holdings' Non Operating Investment Income shows a peak YoY increase of 19331.21% (in 2023) and a maximum YoY decrease of 10352.6% (in 2023) over the last 5 years.
  • Quarter analysis of 4 years shows Orchestra BioMed Holdings' Non Operating Investment Income stood at -$165000.0 in 2022, then crashed by 78.18% to -$294000.0 in 2023, then soared by 40.14% to -$176000.0 in 2024, then surged by 116.48% to $29000.0 in 2025.
  • Its last three reported values are $29000.0 in Q3 2025, -$21000.0 for Q2 2025, and -$15000.0 during Q1 2025.